Isatuximab Plus Pomalidomide and Dexamethasone Association for Patients With AL Amyloidosis Not in VGPR or Better After Any Previous Therapy
Clinical trial NCT05066607 · UNKNOWN
Trial details
- NCT number
- NCT05066607
- Sponsor
- Intergroupe Francophone du Myelome
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-11
- Primary completion
- 2026-03-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.